MedTrace Logo

Effect of Curcumin as Nutraceutical in Patients of Depression

NCT01022632 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-01-28

No results posted yet for this study

Summary

The purpose of this study is to find the effect of commonly used nutraceutical curcumin ( extract of Curcuma longa, commonly called 'Haldi' in Hindi) in patients of depression.

Conditions

Interventions

DIETARY_SUPPLEMENT

Curcumin

Curcumin 500 mg 12 hourly after taking food in morning and evening for 6 weeks

DRUG

Fluoxetine

Fluoxetine ; 20 mg Once a day in morning after taking food for 6 weeks

DIETARY_SUPPLEMENT

Curcumin and Fluoxetine

Curcumin 500 12 hourly after taking food in morning and evening and Fluoxetine 20 mg Once a day in morning after taking food for 6 weeks

Sponsors & Collaborators

  • Health and Family Welfare Department, Government of Gujarat, India

    collaborator UNKNOWN

  • Arjuna Natural Extracts Ltd.

    collaborator INDUSTRY

  • Government Medical College, Bhavnagar

    lead OTHER

Principal Investigators

  • Dr. Bharat Panchal, MD · Professor and Head, Department of Psychiatry, Sir T. General Hospital and Government Medical College, Bhavnagar-364001, Gujarat, India

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01022632 on ClinicalTrials.gov